BNT162b2 mRNA Vaccination Activates Spike-Reactive Regulatory T Cells in Humans.
International immunology·
- DOI
- 10.1093/intimm/dxag045
- PMID
- 42634894
- PMCID
- —
- OpenAlex
- —
- Study type
- Journal article
- Publisher
- Publisher unavailable
- Article type
- journal-article
- Integrity
- current
Why this research matters now
The findings suggest BNT162b2 mRNA vaccination induces both effector and regulatory T cell responses to spike antigen, indicating that Treg co-induction may be important for balancing antiviral immunity with immunoregulation during COVID-19 vaccination.
Structured evidence summary
Research question
The study investigated whether BNT162b2 mRNA COVID-19 vaccination activates spike-reactive regulatory T cells in healthy adults.
Study design
The research combined single-cell RNA sequencing, T cell receptor repertoire profiling, and flow cytometry to analyze spike-reactive CD4+ T cells isolated from peripheral blood mononuclear cells cultured with trimeric spike protein.
Population and setting
The study enrolled healthy adults who received the BNT162b2 mRNA vaccine.
Main findings
Vaccination significantly increased the frequencies of CD39+CTLA4+ and CD39+TIGIT+ spike-reactive Treg-like cells. Two FoxP3+ Treg clusters were identified, both transcriptionally activated post-vaccination with upregulation of genes linked to T cell activation and inflammatory cytokines including TNF and IFNG. Flow cytometry confirmed increased proportions of CD39+ and FoxP3+ spike-reactive Tregs expressing IFN-γ and/or TNF-α following vaccination.
Public-health relevance
The findings suggest BNT162b2 mRNA vaccination induces both effector and regulatory T cell responses to spike antigen, indicating that Treg co-induction may be important for balancing antiviral immunity with immunoregulation during COVID-19 vaccination.
Important limitations
This summary relies on the supplied single-article abstract and metadata. The study appears limited to healthy adults and does not report sample size, follow-up duration, or clinical outcomes. Full interpretation requires access to the complete peer-reviewed manuscript.
GIDS interpretation
This peer-reviewed journal article was classified under COVID-19, SARS, and Vaccination topics, making it discoverable in surveillance systems monitoring vaccine immunology research. The paper characterizes cellular immune responses to mRNA vaccination rather than addressing vaccine safety or effectiveness signals.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 7 auditable classifier relationships to diseases, places, topics, and study design.